Related Experiment Video
Updated: Jan 18, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Successful Treatment of Polyarteritis Nodosa With Multifocal Intracranial and Mesenteric Stenoses Using Endovascular
Mariana Nobre1, Miguel Carrilho1, Angelo Dias2
1Department of Internal Medicine, Local Health Unit of Santa Maria, Lisbon, PRT.
Abstract:
Polyarteritis nodosa (PAN) rarely affects both intracranial and mesenteric arteries. Evidence on optimal timing of revascularisation and the role of interleukin-6 blockade remains limited. A 73-year-old man with longstanding ankylosing spondylitis presented with weight loss and elevated inflammatory markers. Imaging revealed multifocal stenoses in the basilar, anterior, middle and posterior cerebral arteries, alongside a critical 4-cm superior mesenteric artery (SMA) stenosis. Temporal artery histology was negative; anti-neutrophil cytoplasmic antibodies (ANCA) and viral serologies were also negative. A diagnosis of systemic PAN was made. High-dose glucocorticoids and cyclophosphamide normalised inflammatory markers, but severe post-prandial abdominal pain persisted. Endovascular SMA stenting, performed during biochemical remission, resolved the angina and enabled weight recovery. Two years later, the patient developed a lacunar stroke alongside an inflammatory flare and worsening intracranial stenoses. Monthly tocilizumab induced rapid clinical and serological remission, sustained for 18 months. This case highlights that concomitant intracranial and mesenteric stenoses signal high-risk PAN. Additionally, deferring revascularisation until remission improves outcomes, and tocilizumab is a viable steroid-sparing option after cyclophosphamide failure, including cases of PAN with central nervous system involvement.
More Related Videos
04:56Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Pericarditis III: Medical Management